Little Green Pharma’s strong half-year performance signals robust Cannabis growth in Europe and Australia

Little Green Pharma (ASX:LGP) released its half-yearly financial report, showing revenue from ordinary cannabis sales is…

4DMedical inks MOU with Philips to expand XV Technology sales in North America

4DMedical (ASX:4DX) has signed a MOU with Philips to expand sales opportunities for its XV Technology…

Metagenics USA launches MetaSleep powered by The Calmer Co’s Kavaton extract

The Calmer Co International (ASX:CCO) has supplied its Kavaton extract to leading US practitioner supplements brand,…
Pharmaceutical dispensary

MedAdvisor invests $1.9m in UK pharmacy app for 7.4pc share

MedAdvisor (ASX:MDR) has announced it will invest nearly $2 million into UK-based pharmacy dispensary app Charac.

Dimerix gains NMPA approval for IND, opening doors to global phase three tudy on FSGS Treatment

Dimerix (ASX:DXB) has secured approval from the Chinese NMPA Centre for Drug Evaluation (CDE) for its…

Imugene shares soar as FDA grants fast-track designation for cancer-killing drug, Vaxinia

Imugene (ASX:IMU) has reached a milestone in its MAST clinical program using its novel cancer-killing virus,…

EMVision unveils first point-of-care brain scanner device at RSNA 2023

EMVision Medical Devices (ASX:EMV) has revealed the name of its inaugural point-of-care brain scanner device, 'emu',…

Rhythm Biosciences flags positive data for lung cancer diagnostic test

Rhythm Biosciences (ASX:RHY) has received positive preliminary data from the Baker Institute, in regard to its…

Chimeric Therapeutics announces positive preclinical data for CHM 1301

Chimeric Therapeutics (ASX:CHM) has announced positive in vitro data for CHM 1301, the company's next-generation CLTX…

Recce Pharmaceuticals wins Canadian patent for flagship anti-infectives

Recce Pharmaceuticals (ASX:RCE) has announced its receipt of a patent for its anti-infective drugs in Canada.